Anders Åsberg

  • Professor II; PhD
 

Publications 2020

Bjerre A, Mjøen G, Line PD, Naper C, Reisaeter AV, Åsberg A (2020)
Five decades with grandparent donors: The Norwegian strategy and experience
Pediatr Transplant, e13751
DOI 10.1111/petr.13751, PubMed 32485019

Chandra A, Midtvedt K, Åsberg A, Eide IA (2020)
The Authors' Reply: Placental Pathology in Pregnancies After Kidney Transplantation
Transplantation, 104 (7), e216
DOI 10.1097/TP.0000000000003120, PubMed 32569005

Egeland EJ, Witczak BJ, Zaré HK, Christensen H, Åsberg A, Robertsen I (2020)
Chronic Inhibition of CYP3A is Temporarily Reduced by Each Hemodialysis Session in Patients With End-Stage Renal Disease
Clin Pharmacol Ther
DOI 10.1002/cpt.1875, PubMed 32356565

Gustavsen MT, Midtvedt K, Robertsen I, Woillard JB, Debord J, Klaasen RA, Vethe NT, Bergan S, Åsberg A (2020)
Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients
Clin Transl Sci
DOI 10.1111/cts.12833, PubMed 32652886

Gustavsen MT, Midtvedt K, Vethe NT, Robertsen I, Bergan S, Åsberg A (2020)
Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling
Ther Drug Monit, 42 (3), 407-414
DOI 10.1097/FTD.0000000000000697, PubMed 31479042

Nordheim E, Dahle DO, Halden T, Birkeland KI, Åsberg A, Hartmann A, Horneland R, Jenssen TG (2020)
Endothelial function after pancreas transplantation-A single-center observational study
Clin Transplant, 34 (3), e13815
DOI 10.1111/ctr.13815, PubMed 32027399

Pippias M, Jager KJ, Åsberg A, Berger SP, Finne P, Heaf JG, Kerschbaum J, Lempinen M, Magaz Á, Massy ZA, Stel VS (2020)
Young deceased donor kidneys show a survival benefit over older donor kidneys in transplant recipients aged 20-50 years: a study by the ERA-EDTA Registry
Nephrol Dial Transplant, 35 (3), 534-543
DOI 10.1093/ndt/gfy268, PubMed 30203080

Publications 2019

Angeles PC, Robertsen I, Seeberg LT, Krogstad V, Sandbu R, Åsberg A, Hjelmesaeth J (2019)
Reply to letter: "What about drug bioavailability in patients who had bariatric surgery and dependent on immunosuppressives?"
Obes Rev, 21 (2), e12954
DOI 10.1111/obr.12954, PubMed 31746506

Angeles PC, Robertsen I, Seeberg LT, Krogstad V, Skattebu J, Sandbu R, Åsberg A, Hjelmesaeth J (2019)
The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review
Obes Rev, 20 (9), 1299-1311
DOI 10.1111/obr.12869, PubMed 31232513

Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2019)
Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
Blood Press, 29 (2), 123-134
DOI 10.1080/08037051.2019.1684817, PubMed 31718316

Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O et al. (2019)
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
Ther Drug Monit, 41 (3), 261-307
DOI 10.1097/FTD.0000000000000640, PubMed 31045868

Chandra A, Midtvedt K, Åsberg A, Eide IA (2019)
Immunosuppression and Reproductive Health After Kidney Transplantation
Transplantation, 103 (11), e325-e333
DOI 10.1097/TP.0000000000002903, PubMed 31397802

Eide IA, Rashidi F, Lønning K, Oldereid NB, Reisæter AV, Åsberg A, Midtvedt K (2019)
Contraceptive Choices and Counseling in Norwegian Female Renal Transplant Recipients
Transplant Proc, 51 (2), 470-474
DOI 10.1016/j.transproceed.2019.01.068, PubMed 30879570

Gustavsen MT, Midtvedt K, Lønning K, Jacobsen T, Reisaeter AV, De Geest S, Andersen MH, Hartmann A, Åsberg A (2019)
Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial
Transpl Int, 32 (6), 614-625
DOI 10.1111/tri.13412, PubMed 30770608

Halden TAS, Kvitne KE, Midtvedt K, Rajakumar L, Robertsen I, Brox J, Bollerslev J, Hartmann A, Åsberg A, Jenssen T (2019)
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus
Diabetes Care, 42 (6), 1067-1074
DOI 10.2337/dc19-0093, PubMed 30862658

Klaasen RA, Egeland EJ, Chan J, Midtvedt K, Svensson M, Bolstad N, Fellström B, Holdaas H, Åsberg A, Bergan S, Vethe NT, Warren DJ (2019)
A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients
Ther Drug Monit, 41 (1), 11-18
DOI 10.1097/FTD.0000000000000580, PubMed 30633722

Kramer A, Pippias M, Noordzij M, Stel VS, Andrusev AM, Aparicio-Madre MI, Arribas Monzón FE, Åsberg A, Barbullushi M, Beltrán P, Bonthuis M, Caskey FJ, Castro de la Nuez P, Cernevskis H, De Meester J, Finne P, Golan E, Heaf JG, Hemmelder MH, Ioannou K, Kantaria N, Komissarov K, Korejwo G, Kramar R, Lassalle M et al. (2019)
The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary
Clin Kidney J, 12 (5), 702-720
DOI 10.1093/ckj/sfz011, PubMed 31583095

Krogstad V, Peric A, Robertsen I, Kringen MK, Wegler C, Angeles PC, Hjelmesæth J, Karlsson C, Andersson S, Artursson P, Åsberg A, Andersson TB, Christensen H (2019)
A Comparative Analysis of Cytochrome P450 Activities in Paired Liver and Small Intestinal Samples from Patients with Obesity
Drug Metab Dispos, 48 (1), 8-17
DOI 10.1124/dmd.119.087940, PubMed 31685482

Legendre C, Viebahn R, Crespo M, Dor F, Gustafsson B, Samuel U, Karam V, Binet I, Aberg F, De Geest S, Moes DJAR, Tonshoff B, Oppenheimer F, Asberg A, Halleck F, Loupy A, Suesal C (2019)
Beyond Survival in Solid Organ Transplantation: A Summary of Expert Presentations from the Sandoz 6th Standalone Transplantation Meeting, 2018
Transplantation, 103 (9 Suppl 1), S1-S13
DOI 10.1097/TP.0000000000002846, PubMed 31449167

Lorent M, Foucher Y, Kerleau K, Brouard S, Baayen C, Lebouter S, Naesens M, Bestard Matamoros O, Åsberg A, Giral M, EKiTE consortium (2019)
The EKiTE network (epidemiology in kidney transplantation - a European validated database): an initiative epidemiological and translational European collaborative research
BMC Nephrol, 20 (1), 365
DOI 10.1186/s12882-019-1522-8, PubMed 31601177

Midtvedt K, Robertsen I, Asberg A (2019)
Generic drugs - not as similar as we think?
Tidsskr. Nor. Laegeforen., 139 (18), 1722

Midtvedt K, Robertsen I, Åsberg A (2019)
Generic drugs – not as equivalent as we think?
Tidsskr Nor Laegeforen, 139 (18)
DOI 10.4045/tidsskr.19.0740, PubMed 31823584

Quist-Paulsen P, Toft N, Heyman M, Abrahamsson J, Griškevičius L, Hallböök H, Jónsson ÓG, Palk K, Vaitkeviciene G, Vettenranta K, Åsberg A, Frandsen TL, Opdahl S, Marquart HV, Siitonen S, Osnes LT, Hultdin M, Overgaard UM, Wartiovaara-Kautto U, Schmiegelow K (2019)
T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol
Leukemia, 34 (2), 347-357
DOI 10.1038/s41375-019-0598-2, PubMed 31611626

Robertsen I, Woillard JB, Åsberg A (2019)
Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus-treated transplant recipients?
Br J Clin Pharmacol (in press)
DOI 10.1111/bcp.13984, PubMed 31144343

Skulberg AK, Åsberg A, Khiabani HZ, Røstad H, Tylleskar I, Dale O (2019)
Pharmacokinetics of a novel, approved, 1.4-mg intranasal naloxone formulation for reversal of opioid overdose-a randomized controlled trial
Addiction, 114 (5), 859-867
DOI 10.1111/add.14552, PubMed 30644628

Tantiyavarong P, Kramer A, Heaf JG, Finne P, Åsberg A, Cases A, Caskey FJ, Massy ZA, Jager KJ, Noordzij M (2019)
Changes in clinical indicators related to the transition from dialysis to kidney transplantation-data from the ERA-EDTA Registry
Clin Kidney J, 13 (2), 188-198
DOI 10.1093/ckj/sfz062, PubMed 32296524

Thorsen IS, Bleskestad IH, Åsberg A, Hartmann A, Skadberg Ø, Brede C, Ueland T, Pasch A, Reisaeter AV, Gøransson LG (2019)
Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study
Clin Transplant, 33 (5), e13517
DOI 10.1111/ctr.13517, PubMed 30844090

Ussif AM, Åsberg A, Halden TAS, Nordheim E, Hartmann A, Jenssen T (2019)
Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation
BMC Nephrol, 20 (1), 12
DOI 10.1186/s12882-018-1171-3, PubMed 30630438

Vethe NT, Gustavsen MT, Midtvedt K, Lauritsen ME, Andersen AM, Åsberg A, Bergan S (2019)
Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients
Ther Drug Monit, 41 (5), 607-614
DOI 10.1097/FTD.0000000000000655, PubMed 31584926

Åsberg A, Bjerre A, Almaas R, Luis-Lima S, Robertsen I, Salvador CL, Porrini E, Schwartz GJ, Hartmann A, Bergan S (2019)
Measured GFR by Utilizing Population Pharmacokinetic Methods to Determine Iohexol Clearance
Kidney Int Rep, 5 (2), 189-198
DOI 10.1016/j.ekir.2019.11.012, PubMed 32043033

Publications 2018

Chandra A, Svensson M, Åsberg A, Schmidt EB, Bjerve KS, Jenssen T, Hartmann A, Ueland T, Eide IA (2018)
Trans-fatty Acids and Survival in Renal Transplantation
J Ren Nutr, 29 (3), 169-180
DOI 10.1053/j.jrn.2018.08.003, PubMed 30309780

Egeland EJ, Reisaeter AV, Robertsen I, Midtvedt K, Strøm EH, Holdaas H, Hartmann A, Åsberg A (2018)
High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study
Transpl Int, 32 (3), 257-269
DOI 10.1111/tri.13356, PubMed 30252957

Egeland EJ, Størset E, Robertsen I, Hermann M, Midtvedt K, Gustavsen MT, Klaasen R, Bergan S, Hartmann A, Åsberg A (2018)
The Authors' Reply
Transplantation, 102 (1), e43-e44
DOI 10.1097/TP.0000000000001961, PubMed 28957846

Eide IA, Reinholt FP, Jenssen T, Hartmann A, Schmidt EB, Åsberg A, Bergan S, Brabrand K, Svensson M (2018)
Effects of marine n-3 fatty acid supplementation in renal transplantation: A randomized controlled trial
Am J Transplant, 19 (3), 790-800
DOI 10.1111/ajt.15080, PubMed 30125457

Foss S, Nordheim E, Sørensen DW, Syversen TB, Midtvedt K, Åsberg A, Dahl T, Bakkan PA, Foss AE, Geiran OR, Fiane AE, Line PD (2018)
First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion
Transplant Direct, 4 (7), e366
DOI 10.1097/TXD.0000000000000802, PubMed 30046656

García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Reisaeter AV, Seron D (2018)
Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantation
Clin Transplant, 32 (3), e13196
DOI 10.1111/ctr.13196, PubMed 29380890

Heldal K, Midtvedt K, Hartmann A, Reisaeter AV, Heldal TF, Bergan S, Salvador CL, Åsberg A (2018)
Estimated glomerular filtration rate in stable older kidney transplant recipients-are present algorithms valid? A national cross-sectional cohort study
Transpl Int, 31 (6), 629-638
DOI 10.1111/tri.13137, PubMed 29453878

Heldal TF, Ueland T, Jenssen T, Hartmann A, Reisaeter AV, Aukrust P, Michelsen A, Åsberg A (2018)
Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study
Transpl Int, 31 (5), 510-519
DOI 10.1111/tri.13116, PubMed 29341300

Hjelmesæth J, Åsberg A, Andersson S, Sandbu R, Robertsen I, Johnson LK, Angeles PC, Hertel JK, Skovlund E, Heijer M, Ek AL, Krogstad V, Karlsen TI, Christensen H, Andersson TB, Karlsson C (2018)
Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)
BMJ Open, 8 (5), e021878
DOI 10.1136/bmjopen-2018-021878, PubMed 29844102

Kramer A, Pippias M, Noordzij M, Stel VS, Afentakis N, Ambühl PM, Andrusev AM, Fuster EA, Arribas Monzón FE, Åsberg A, Barbullushi M, Bonthuis M, Caskey FJ, Castro de la Nuez P, Cernevskis H, des Grottes JM, Garneata L, Golan E, Hemmelder MH, Ioannou K, Jarraya F, Kolesnyk M, Komissarov K, Lassalle M, Macario F et al. (2018)
The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary
Clin Kidney J, 11 (1), 108-122
DOI 10.1093/ckj/sfx149, PubMed 29423210

Krogstad V, Vethe NT, Robertsen I, Hasvold G, Ose AD, Hermann M, Andersen AM, Chan J, Skauby M, Svensson MHS, Åsberg A, Christensen H (2018)
Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core Biopsies
Ther Drug Monit, 40 (3), 292-300
DOI 10.1097/FTD.0000000000000510, PubMed 29578937

Nordheim E, Birkeland KI, Åsberg A, Hartmann A, Horneland R, Jenssen T (2018)
Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational study
Eur J Endocrinol, 179 (4), 251-259
DOI 10.1530/EJE-18-0360, PubMed 30299895

Robertsen I, Debord J, Åsberg A, Marquet P, Woillard JB (2018)
A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian Estimators
Clin Pharmacokinet, 57 (11), 1459-1469
DOI 10.1007/s40262-018-0646-5, PubMed 29556934

Skaare H, Svensson M, Jenssen T, Åsberg A, Schmidt EB, Chandra A, Ueland T, Mollnes TE, Hartmann A, Eide IA (2018)
Plasma n-6 Polyunsaturated Fatty Acid Levels and Survival in Renal Transplantation
J Ren Nutr, 28 (5), 333-339
DOI 10.1053/j.jrn.2018.02.008, PubMed 29703632

Thorsteinsdottir H, Diseth TH, Lie A, Tangeraas T, Matthews I, Åsberg A, Bjerre A (2018)
Small effort, high impact: Focus on physical activity improves oxygen uptake (VO2peak ), quality of life, and mental health after pediatric renal transplantation
Pediatr Transplant, 22 (6), e13242
DOI 10.1111/petr.13242, PubMed 29921004

Ussif A, Pihlstrøm H, Pasch A, Holdaas H, Hartmann A, Smerud K, Åsberg A (2018)
Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
BMC Nephrol, 19 (1), 212
DOI 10.1186/s12882-018-1000-8, PubMed 30134956

von Düring ME, Jenssen T, Bollerslev J, Godang K, Hartmann A, Åsberg A (2018)
Arterial stiffness is associated with visceral fat mass in kidney transplanted patients-A nationwide cohort study
Clin Transplant, 32 (8), e13341
DOI 10.1111/ctr.13341, PubMed 29957825

Woillard JB, Saint-Marcoux F, Debord J, Åsberg A (2018)
Pharmacokinetic models to assist the prescriber in choosing the best tacrolimus dose
Pharmacol Res, 130, 316-321
DOI 10.1016/j.phrs.2018.02.016, PubMed 29452291

Publications 2017

Apeland T, Danielsen T, Staal EM, Åsberg A, Thorsen IS, Dalsrud TO, Ørn S (2017)
Risk factors for exertional rhabdomyolysis with renal stress
BMJ Open Sport Exerc Med, 3 (1), e000241
DOI 10.1136/bmjsem-2017-000241, PubMed 29147573

Dupont L, Eide IA, Hartmann A, Christensen JH, Åsberg A, Jenssen T, Krarup H, Svensson M (2017)
Haptoglobin 2-2 Genotype, Patient, and Graft Survival in Renal Transplant Recipients
Prog Transplant, 27 (4), 386-391
DOI 10.1177/1526924817732020, PubMed 29187131

Egeland EJ, Robertsen I, Hermann M, Midtvedt K, Størset E, Gustavsen MT, Reisæter AV, Klaasen R, Bergan S, Holdaas H, Hartmann A, Åsberg A (2017)
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation
Transplantation, 101 (8), e273-e279
DOI 10.1097/TP.0000000000001796, PubMed 28452920

Eide IA, Dörje C, Svensson M, Jenssen T, Hammarstrøm C, Scott H, Bjerve KS, Christensen JH, Schmidt EB, Hartmann A, Åsberg A, Reisæter AV, Reinholt FP (2017)
Development of Kidney Transplant Fibrosis Is Inversely Associated With Plasma Marine Fatty Acid Level
J Ren Nutr, 28 (2), 118-124
DOI 10.1053/j.jrn.2017.09.001, PubMed 29146138

Eide IA, Halden TAS, Hartmann A, Dahle DO, Åsberg A, Jenssen T (2017)
Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival
Transplantation, 101 (6), 1282-1289
DOI 10.1097/TP.0000000000001259, PubMed 27362306

García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV (2017)
Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies
Transplantation, 101 (6), 1410-1415
DOI 10.1097/TP.0000000000001216, PubMed 27163535

Hole K, Størset E, Olastuen A, Haslemo T, Kro GB, Midtvedt K, Åsberg A, Molden E (2017)
Recovery of CYP3A Phenotype after Kidney Transplantation
Drug Metab Dispos, 45 (12), 1260-1265
DOI 10.1124/dmd.117.078030, PubMed 28928137

Lindahl JP, Horneland R, Nordheim E, Hartmann A, Aandahl EM, Grzyb K, Haugaa H, Kjøsen G, Åsberg A, Jenssen T (2017)
Outcomes in Pancreas Transplantation With Exocrine Drainage Through a Duodenoduodenostomy Versus Duodenojejunostomy
Am J Transplant, 18 (1), 154-162
DOI 10.1111/ajt.14420, PubMed 28696022

Midtvedt K, Bergan S, Reisæter AV, Vikse BE, Åsberg A (2017)
Exposure to Mycophenolate and Fatherhood
Transplantation, 101 (7), e214-e217
DOI 10.1097/TP.0000000000001747, PubMed 28346297

Midtvedt K, Holdaas H, Bergan S, Åsberg A (2017)
Costimulation Blockade: America First, Canada Second … What About Norway?
Am J Transplant, 17 (8), 2230
DOI 10.1111/ajt.14351, PubMed 28508535

Midtvedt K, Åsberg A (2017)
Mycophenolate Acid and Balancing the Risk for Male Allograft Recipients
Transplantation, 101 (1), e39
DOI 10.1097/TP.0000000000001509, PubMed 27748704

Pippias M, Kramer A, Noordzij M, Afentakis N, Alonso de la Torre R, Ambühl PM, Aparicio Madre MI, Arribas Monzón F, Åsberg A, Bonthuis M, Bouzas Caamaño E, Bubic I, Caskey FJ, Castro de la Nuez P, Cernevskis H, de Los Ángeles Garcia Bazaga M, des Grottes JM, Fernández González R, Ferrer-Alamar M, Finne P, Garneata L, Golan E, Heaf JG, Hemmelder MH, Idrizi A et al. (2017)
The European Renal Association - European Dialysis and Transplant Association Registry Annual Report 2014: a summary
Clin Kidney J, 10 (2), 154-169
DOI 10.1093/ckj/sfw135, PubMed 28584624

Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU (2017)
Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection
PLoS Pathog, 13 (5), e1006386
DOI 10.1371/journal.ppat.1006386, PubMed 28489893

Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU (2017)
Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection
PLoS Pathog, 13 (4), e1006299
DOI 10.1371/journal.ppat.1006299, PubMed 28406982

Salvador CL, Hartmann A, Åsberg A, Bergan S, Rowe AD, Mørkrid L (2017)
Estimating Glomerular Filtration Rate in Kidney Transplant Recipients: Comparing a Novel Equation With Commonly Used Equations in this Population
Transplant Direct, 3 (12), e332
DOI 10.1097/TXD.0000000000000742, PubMed 29536033

Smerud KT, Åsberg A, Kile H, Pasch A, Dahle DO, Bollerslev J, Godang K, Hartmann A (2017)
A rapid and sustained improvement of calcification propensity score (serum T50 ) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate
Clin Transplant, 31 (12)
DOI 10.1111/ctr.13131, PubMed 28972673

Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'
Br J Clin Pharmacol, 83 (6), 1357-1358
DOI 10.1111/bcp.13276, PubMed 28374426

Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation
Br J Clin Pharmacol, 83 (7), 1457-1465
DOI 10.1111/bcp.13248, PubMed 28146606

Toft N, Birgens H, Abrahamsson J, Griškevičius L, Hallböök H, Heyman M, Klausen TW, Jónsson ÓG, Palk K, Pruunsild K, Quist-Paulsen P, Vaitkeviciene G, Vettenranta K, Åsberg A, Frandsen TL, Marquart HV, Madsen HO, Norén-Nyström U, Schmiegelow K (2017)
Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia
Leukemia, 32 (3), 606-615
DOI 10.1038/leu.2017.265, PubMed 28819280

Torres IB, Reisaeter AV, Moreso F, Âsberg A, Vidal M, Garcia-Carro C, Midtvedt K, Reinholt FP, Scott H, Castellà E, Salcedo M, Dörje C, Sellarés J, Azancot MA, Perello M, Holdaas H, Serón D (2017)
Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants
Transpl Int, 30 (11), 1119-1131
DOI 10.1111/tri.13002, PubMed 28667664

Åsberg A, Robertsen I, Midtvedt K (2017)
How to Report and Interpret Bioequivalence Data in Solid Organ Transplant Recipients
Transplantation, 101 (11), e347
DOI 10.1097/TP.0000000000001894, PubMed 28787310

Publications 2016

Eide IA, Dahle DO, Svensson M, Hartmann A, Åsberg A, Bjerve KS, Christensen JH, Schmidt EB, Lauritsen ME, Lund K, Jenssen T (2016)
Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipients
Eur J Clin Nutr, 70 (7), 824-30
DOI 10.1038/ejcn.2016.14, PubMed 26931669

Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisaeter AV, Jenssen T (2016)
Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria
Transpl Int, 29 (5), 568-78
DOI 10.1111/tri.12757, PubMed 26875590

Eide IA, Åsberg A, Svensson M, Ueland T, Mollnes TE, Hartmann A, Bjerve KS, Michelsen A, Aukrust P, Christensen JH, Schmidt EB, Jenssen T (2016)
Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant Recipients
J Ren Nutr, 27 (3), 161-168
DOI 10.1053/j.jrn.2016.09.008, PubMed 27838193

Halden TA, Egeland EJ, Åsberg A, Hartmann A, Midtvedt K, Khiabani HZ, Holst JJ, Knop FK, Hornum M, Feldt-Rasmussen B, Jenssen T (2016)
GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes
Diabetes Care, 39 (4), 617-24
DOI 10.2337/dc15-2383, PubMed 26908914

Jørgensen HS, Eide IA, Hartmann A, Åsberg A, Christensen JH, Schmidt EB, Godang K, Bollerslev J, Svensson M (2016)
Plasma n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Renal Transplant Recipients
J Ren Nutr, 26 (3), 196-203
DOI 10.1053/j.jrn.2015.11.007, PubMed 26776249

Koopman JJ, Kramer A, van Heemst D, Åsberg A, Beuscart JB, Buturović-Ponikvar J, Collart F, Couchoud CG, Finne P, Heaf JG, Massy ZA, De Meester JM, Palsson R, Steenkamp R, Traynor JP, Jager KJ, Putter H (2016)
Measuring senescence rates of patients with end-stage renal disease while accounting for population heterogeneity: an analysis of data from the ERA-EDTA Registry
Ann Epidemiol, 26 (11), 773-779
DOI 10.1016/j.annepidem.2016.08.010, PubMed 27665405

Nordheim E, Dahle DO, Syse IM, Åsberg A, Reisæter AV, Hartmann A (2016)
Resolution of Calciphylaxis After Urgent Kidney Transplantation in 3 Patients With End-Stage Kidney Failure
Transplant Direct, 2 (11), e113
DOI 10.1097/TXD.0000000000000627, PubMed 27826606

Smedbråten J, Mjøen G, Hartmann A, Åsberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
BMC Nephrol, 17 (1), 148
DOI 10.1186/s12882-016-0373-9, PubMed 27760523

Smedbråten J, Sagedal S, Åsberg A, Hartmann A, Rollag H, Mjøen G, Fagerland MW, Hansen SW, Mollnes TE, Thiel S (2016)
Collectin Liver 1 and Collectin Kidney 1 of the Lectin Complement Pathway Are Associated With Mortality After Kidney Transplantation
Am J Transplant, 17 (1), 265-271
DOI 10.1111/ajt.13933, PubMed 27341702

Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2016)
Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance
Br J Clin Pharmacol, 83 (6), 1350-1352
DOI 10.1111/bcp.13188, PubMed 28008657

Størset E, von Düring ME, Godang K, Bergan S, Midtvedt K, Åsberg A (2016)
Prediction of Fat-Free Mass in Kidney Transplant Recipients
Ther Drug Monit, 38 (4), 439-46
DOI 10.1097/FTD.0000000000000305, PubMed 27019101

Størset E, Åsberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K (2016)
Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience
Nephrology (Carlton), 21 (10), 821-7
DOI 10.1111/nep.12738, PubMed 26854648

von Düring ME, Jenssen T, Bollerslev J, Åsberg A, Godang K, Hartmann A (2016)
Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1 year after kidney transplantation
Clin Transplant, 31 (1)
DOI 10.1111/ctr.12869, PubMed 27859633

Åsberg A, Humar A, Rollag H, Jardine AG, Kumar D, Aukrust P, Ueland T, Bignamini AA, Hartmann A (2016)
Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial
Clin Infect Dis, 62 (9), 1154-60
DOI 10.1093/cid/ciw084, PubMed 26908810

Publications 2015

Dahle DO, Eide IA, Åsberg A, Leivestad T, Holdaas H, Jenssen TG, Fagerland MW, Pihlstrøm H, Mjøen G, Hartmann A (2015)
Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
Transplantation, 99 (8), 1730-7
DOI 10.1097/TP.0000000000000660, PubMed 25757216

Dahle DO, Åsberg A, Hartmann A, Holdaas H, Bachtler M, Jenssen TG, Dionisi M, Pasch A (2015)
Serum Calcification Propensity Is a Strong and Independent Determinant of Cardiac and All-Cause Mortality in Kidney Transplant Recipients
Am J Transplant, 16 (1), 204-12
DOI 10.1111/ajt.13443, PubMed 26375609

Egli A, Lisboa LF, O'Shea D, Asberg A, Mueller T, Emery V, Kumar D, Humar A (2015)
Complexity of Host Micro-RNA Response to Cytomegalovirus Reactivation After Organ Transplantation
Am J Transplant, 16 (2), 650-60
DOI 10.1111/ajt.13464, PubMed 26460801

Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisæter AV, Jenssen T (2015)
Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus
Transplantation, 99 (3), 629-35
DOI 10.1097/TP.0000000000000376, PubMed 25162478

Lisboa LF, Egli A, O'Shea D, Åsberg A, Hartmann A, Rollag H, Pang XL, Tyrrell DL, Kumar D, Humar A (2015)
Hcmv-miR-UL22A-5p: A Biomarker in Transplantation With Broad Impact on Host Gene Expression and Potential Immunological Implications
Am J Transplant, 15 (7), 1893-902
DOI 10.1111/ajt.13222, PubMed 25833298

Robertsen I, Vethe NT, Midtvedt K, Falck P, Christensen H, Åsberg A (2015)
Closer to the Site of Action: Everolimus Concentrations in Peripheral Blood Mononuclear Cells Correlate Well With Whole Blood Concentrations
Ther Drug Monit, 37 (5), 675-80
DOI 10.1097/FTD.0000000000000185, PubMed 25565673

Robertsen I, Åsberg A, Ingerø AO, Vethe NT, Bremer S, Bergan S, Midtvedt K (2015)
Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed
Transplantation, 99 (3), 528-32
DOI 10.1097/TP.0000000000000384, PubMed 25148382

Størset E, Åsberg A, Skauby M, Neely M, Bergan S, Bremer S, Midtvedt K (2015)
Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study
Transplantation, 99 (10), 2158-66
DOI 10.1097/TP.0000000000000708, PubMed 25886918

Ueland T, Rollag H, Hartmann A, Jardine A, Humar A, Bignamini AA, Åsberg A, Aukrust P (2015)
Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients
Transplantation, 99 (1), 100-5
DOI 10.1097/TP.0000000000000227, PubMed 24983306

von Düring ME, Jenssen T, Bollerslev J, Åsberg A, Godang K, Eide IA, Dahle DO, Hartmann A (2015)
Visceral fat is better related to impaired glucose metabolism than body mass index after kidney transplantation
Transpl Int, 28 (10), 1162-71
DOI 10.1111/tri.12606, PubMed 25970153

Publications 2014

Dahle DO, Jenssen T, Holdaas H, Asberg A, Soveri I, Holme I, Mjøen G, Eide IA, Pihlstrøm H, Dörje C, Halden TA, Hartmann A (2014)
Uric acid and clinical correlates of endothelial function in kidney transplant recipients
Clin Transplant, 28 (10), 1167-76
DOI 10.1111/ctr.12435, PubMed 25124959

Lunde I, Bremer S, Midtvedt K, Mohebi B, Dahl M, Bergan S, Åsberg A, Christensen H (2014)
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
Eur J Clin Pharmacol, 70 (6), 685-93
DOI 10.1007/s00228-014-1656-3, PubMed 24658827

Robertsen I, Asberg A, Granseth T, Vethe NT, Akhlaghi F, Ghareeb M, Molden E, Reier-Nilsen M, Holdaas H, Midtvedt K (2014)
More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients
Transplantation, 97 (12), 1266-71
DOI 10.1097/01.TP.0000443225.66960.7e, PubMed 24521776

Strøm Halden TA, Åsberg A, Vik K, Hartmann A, Jenssen T (2014)
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation
Nephrol Dial Transplant, 29 (4), 926-33
DOI 10.1093/ndt/gft536, PubMed 24452849

Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, Åsberg A, Midtvedt K, Staatz CE (2014)
Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
Br J Clin Pharmacol, 78 (3), 509-23
DOI 10.1111/bcp.12361, PubMed 25279405

Publications 2013

Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjøen G, Leivestad T, Asberg A (2013)
Endothelial dysfunction is associated with graft loss in renal transplant recipients
Transplantation, 95 (5), 733-9
DOI 10.1097/TP.0b013e31827d6312, PubMed 23364481

Darwich AS, Pade D, Rowland-Yeo K, Jamei M, Asberg A, Christensen H, Ashcroft DM, Rostami-Hodjegan A (2013)
Evaluation of an In Silico PBPK Post-Bariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and Cyclosporine
CPT Pharmacometrics Syst Pharmacol, 2, e47
DOI 10.1038/psp.2013.23, PubMed 23903405

Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, Humar A, Transplantation Society International CMV Consensus Group (2013)
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
Transplantation, 96 (4), 333-60
DOI 10.1097/TP.0b013e31829df29d, PubMed 23896556

Razonable RR, Åsberg A, Rollag H, Duncan J, Boisvert D, Yao JD, Caliendo AM, Humar A, Do TD (2013)
Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients
Clin Infect Dis, 56 (11), 1546-53
DOI 10.1093/cid/cit096, PubMed 23418272

Robertsen I, Falck P, Andreassen AK, Næss NK, Lunder N, Christensen H, Gullestad L, Asberg A (2013)
Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients
Transplant Res, 2 (1), 5
DOI 10.1186/2047-1440-2-5, PubMed 23566530

Rollag H, Ueland T, Asberg A, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2013)
Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma
PLoS One, 8 (4), e60767
DOI 10.1371/journal.pone.0060767, PubMed 23593305

Stormo C, Bogsrud MP, Hermann M, Åsberg A, Piehler AP, Retterstøl K, Kringen MK (2013)
UGT1A1*28 is associated with decreased systemic exposure of atorvastatin lactone
Mol Diagn Ther, 17 (4), 233-7
DOI 10.1007/s40291-013-0031-x, PubMed 23580084

Størset E, Holford N, Midtvedt K, Bremer S, Bergan S, Åsberg A (2013)
Importance of hematocrit for a tacrolimus target concentration strategy
Eur J Clin Pharmacol, 70 (1), 65-77
DOI 10.1007/s00228-013-1584-7, PubMed 24071959

Tøndell A, Rø AD, Åsberg A, Børset M, Moen T, Sue-Chu M (2013)
Activated CD8(+) T cells and NKT cells in BAL fluid improve diagnostic accuracy in sarcoidosis
Lung, 192 (1), 133-40
DOI 10.1007/s00408-013-9527-8, PubMed 24213536

Ueland T, Rollag H, Hartmann A, Jardine AG, Humar A, Michelsen AE, Bignamini AA, Åsberg A, Aukrust P (2013)
Secreted Wnt antagonists during eradication of cytomegalovirus infection in solid organ transplant recipients
Am J Transplant, 14 (1), 210-5
DOI 10.1111/ajt.12506, PubMed 24224707

Vaitkeviciene G, Heyman M, Jonsson OG, Lausen B, Harila-Saari A, Stenmarker M, Taskinen M, Zvirblis T, Åsberg A, Groth-Pedersen L, Rageliene L, Schmiegelow K (2013)
Early morbidity and mortality in childhood acute lymphoblastic leukemia with very high white blood cell count
Leukemia, 27 (11), 2259-62
DOI 10.1038/leu.2013.137, PubMed 23689480

Åsberg A, Apeland T, Reisaeter AV, Foss A, Leivestad T, Heldal K, Thorud LO, Eriksen BO, Hartmann A, NILS Study Group (2013)
Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial
Clin Transplant, 27 (2), E151-6
DOI 10.1111/ctr.12076, PubMed 23351013

Åsberg A, Bjerre A, Neely M (2013)
New algorithm for valganciclovir dosing in pediatric solid organ transplant recipients
Pediatr Transplant, 18 (1), 103-11
DOI 10.1111/petr.12179, PubMed 24152053

Åsberg A, Midtvedt K, van Guilder M, Størset E, Bremer S, Bergan S, Jelliffe R, Hartmann A, Neely MN (2013)
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
Transpl Int, 26 (12), 1198-207
DOI 10.1111/tri.12194, PubMed 24118301

Åsberg AE, Mikkelsen G, Aune MW, Åsberg A (2013)
Empty iron stores in children and young adults--the diagnostic accuracy of MCV, MCH, and MCHC
Int J Lab Hematol, 36 (1), 98-104
DOI 10.1111/ijlh.12132, PubMed 23941574

Publications 2012

Akhlaghi F, Dostalek M, Falck P, Mendonza AE, Amundsen R, Gohh RY, Asberg A (2012)
The concentration of cyclosporine metabolites is significantly lower in kidney transplant recipients with diabetes mellitus
Ther Drug Monit, 34 (1), 38-45
DOI 10.1097/FTD.0b013e318241ac71, PubMed 22210099

Emery VC, Manuel O, Asberg A, Pang X, Kumar D, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Gahlemann CG, Humar A (2012)
Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy
J Clin Virol, 54 (1), 56-60
DOI 10.1016/j.jcv.2012.01.015, PubMed 22410132

Holdaas H, Midtvedt K, Åsberg A (2012)
A drug safety evaluation of everolimus in kidney transplantation
Expert Opin Drug Saf, 11 (6), 1013-22
DOI 10.1517/14740338.2012.722993, PubMed 22954349

Jakobsen GS, Skottheim IB, Sandbu R, Christensen H, Røislien J, Asberg A, Hjelmesæth J (2012)
Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin
Surg Endosc, 27 (6), 2094-101
DOI 10.1007/s00464-012-2716-3, PubMed 23247745

Loftheim H, Midtvedt K, Hartmann A, Reisæter AV, Falck P, Holdaas H, Jenssen T, Reubsaet L, Asberg A (2012)
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
Transplant Res, 1 (1), 9
DOI 10.1186/2047-1440-1-9, PubMed 23369437

Rollag H, Asberg A, Ueland T, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2012)
Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome
Transplantation, 94 (10), 1060-5
DOI 10.1097/TP.0b013e31826c39de, PubMed 23104251

Smerud KT, Dolgos S, Olsen IC, Åsberg A, Sagedal S, Reisæter AV, Midtvedt K, Pfeffer P, Ueland T, Godang K, Bollerslev J, Hartmann A (2012)
A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
Am J Transplant, 12 (12), 3316-25
DOI 10.1111/j.1600-6143.2012.04233.x, PubMed 22946930

Ulvestad M, Bjorquist P, Molden E, Asberg A, Andersson TB (2012)
OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture (vol 82, pg 1219, 2011)
Biochem. Pharmacol., 84 (8), 1103

Ulvestad M, Darnell M, Molden E, Ellis E, Åsberg A, Andersson TB (2012)
Evaluation of organic anion-transporting polypeptide 1B1 and CYP3A4 activities in primary human hepatocytes and HepaRG cells cultured in a dynamic three-dimensional bioreactor system
J Pharmacol Exp Ther, 343 (1), 145-56
DOI 10.1124/jpet.112.195750, PubMed 22789711

Ulvestad M, Skottheim IB, Jakobsen GS, Bremer S, Molden E, Asberg A, Hjelmesæth J, Andersson TB, Sandbu R, Christensen H (2012)
Impact of OATP1B1, MDR1, and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjects
Clin Pharmacol Ther, 93 (3), 275-82
DOI 10.1038/clpt.2012.261, PubMed 23361102

Publications 2011

Amundsen R, Åsberg A, Ohm IK, Christensen H (2011)
Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro
Drug Metab Dispos, 40 (4), 655-61
DOI 10.1124/dmd.111.043018, PubMed 22205779

Asberg A, Jardine AG, Bignamini AA, Rollag H, Gahlemann CC, Humar A, Hartmann A (2011)
Response to letter about intensity of immunosuppressive therapy on outcome of treatment for CMV disease
Am J Transplant, 11 (5), 1103-4
DOI 10.1111/j.1600-6143.2011.03500.x, PubMed 21521477

Lisboa LF, Asberg A, Kumar D, Pang X, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Humar A (2011)
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response
Transplantation, 91 (2), 231-6
DOI 10.1097/TP.0b013e3181ff8719, PubMed 21048530

Lisboa LF, Tong Y, Kumar D, Pang XL, Asberg A, Hartmann A, Rollag H, Jardine AG, Pescovitz MD, Humar A (2011)
Analysis and clinical correlation of genetic variation in cytomegalovirus
Transpl Infect Dis, 14 (2), 132-40
DOI 10.1111/j.1399-3062.2011.00685.x, PubMed 22093996

Midtvedt K, Jenssen T, Hartmann A, Vethe NT, Bergan S, Havnes K, Åsberg A (2011)
No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus
Nephrol Dial Transplant, 26 (11), 3767-72
DOI 10.1093/ndt/gfr153, PubMed 21471328

Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A (2011)
Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients
Transplantation, 92 (2), 217-23
DOI 10.1097/TP.0b013e31821fad25, PubMed 21685829

Skottheim IB, Bogsrud MP, Hermann M, Retterstøl K, Åsberg A (2011)
Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy
Mol Diagn Ther, 15 (4), 221-7
DOI 10.1007/BF03256413, PubMed 21815705

Ulvestad M, Björquist P, Molden E, Asberg A, Andersson TB (2011)
OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture
Biochem Pharmacol, 82 (9), 1219-26
DOI 10.1016/j.bcp.2011.07.076, PubMed 21787759

Vethe NT, Midtvedt K, Asberg A, Amundsen R, Bergan S (2011)
[Drug interactions and immunosuppression in organ transplant recipients]
Tidsskr Nor Laegeforen, 131 (20), 2000-3
DOI 10.4045/tidsskr.11.0138, PubMed 22016125

Publications 2010

Amundsen R, Christensen H, Zabihyan B, Asberg A (2010)
Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin
Drug Metab Dispos, 38 (9), 1499-504
DOI 10.1124/dmd.110.032268, PubMed 20519340

Asberg A, Falck P, Undset LH, Dørje C, Holdaas H, Hartmann A, Midtvedt K (2010)
Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot study
Ther Drug Monit, 32 (2), 152-8
DOI 10.1097/FTD.0b013e3181d3f822, PubMed 20216113

Asberg A, Jardine AG, Bignamini AA, Rollag H, Pescovitz MD, Gahlemann CC, Humar A, Hartmann A, VICTOR Study Group (2010)
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients
Am J Transplant, 10 (8), 1881-8
DOI 10.1111/j.1600-6143.2010.03114.x, PubMed 20486914

Asberg A, Rollag H, Hartmann A (2010)
Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients
Expert Opin Pharmacother, 11 (7), 1159-66
DOI 10.1517/14656561003742954, PubMed 20367273

Ellesat KS, Tollefsen KE, Asberg A, Thomas KV, Hylland K (2010)
Cytotoxicity of atorvastatin and simvastatin on primary rainbow trout (Oncorhynchus mykiss) hepatocytes
Toxicol In Vitro, 24 (6), 1610-8
DOI 10.1016/j.tiv.2010.06.006, PubMed 20600806

Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A, Transplantation Society International CMV Consensus Group (2010)
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation
Transplantation, 89 (7), 779-95
DOI 10.1097/TP.0b013e3181cee42f, PubMed 20224515

Loftheim H, Asberg A, Reubsaet L (2010)
Accelerated 18O-labeling in urinary proteomics
J Chromatogr A, 1217 (52), 8241-8
DOI 10.1016/j.chroma.2010.10.119, PubMed 21094492

Loftheim H, Nguyen TD, Malerød H, Lundanes E, Asberg A, Reubsaet L (2010)
2-D hydrophilic interaction liquid chromatography-RP separation in urinary proteomics--minimizing variability through improved downstream workflow compatibility
J Sep Sci, 33 (6-7), 864-72
DOI 10.1002/jssc.200900554, PubMed 20024930

Narwal R, Akhlaghi F, Asberg A, Hermann M, Rosenbaum SE (2010)
Development of a population pharmacokinetic model for atorvastatin acid and its lactone metabolite
Clin Pharmacokinet, 49 (10), 693-702
DOI 10.2165/11535980-000000000-00000, PubMed 20818835

Skottheim IB, Jakobsen GS, Stormark K, Christensen H, Hjelmesaeth J, Jenssen T, Asberg A, Sandbu R (2010)
Significant increase in systemic exposure of atorvastatin after biliopancreatic diversion with duodenal switch
Clin Pharmacol Ther, 87 (6), 699-705
DOI 10.1038/clpt.2010.32, PubMed 20445535

Publications 2009

Amundsen R, Asberg A, Robertsen I, Vethe NT, Bergan S, Hartmann A, Midtvedt K (2009)
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients
Transplantation, 87 (8), 1221-4
DOI 10.1097/TP.0b013e31819f1001, PubMed 19384170

Asberg A, Humar A, Jardine AG, Rollag H, Pescovitz MD, Mouas H, Bignamini A, Töz H, Dittmer I, Montejo M, Hartmann A, VICTOR Study Group (2009)
Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients
Am J Transplant, 9 (5), 1205-13
DOI 10.1111/j.1600-6143.2009.02617.x, PubMed 19422345

Asberg A, Midtvedt K, Voytovich MH, Line PD, Narverud J, Reisaeter AV, Mørkrid L, Jenssen T, Hartmann A (2009)
Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation
Clin Transplant, 23 (4), 511-8
DOI 10.1111/j.1399-0012.2009.00962.x, PubMed 19210527

Boivin G, Goyette N, Rollag H, Jardine AG, Pescovitz MD, Asberg A, Ives J, Hartmann A, Humar A (2009)
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir
Antivir Ther, 14 (5), 697-704
PubMed 19704173

Falck P, Midtvedt K, Vân Lê TT, Storehagen L, Holdaas H, Hartmann A, Asberg A (2009)
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients
Clin Pharmacokinet, 48 (9), 615-23
DOI 10.2165/11313380-000000000-00000, PubMed 19725595

Hoyem S, Bruheim S, Maelandsmo G, Standal M, Olberg DE, Brudeli B, Asberg A, Klaveness J, Rongved P (2009)
Didanosine ester prodrugs: Synthesis, albumin binding properties and pharmacokinetic studies in rats (vol 44, pg 3874, 2009)
Eur. J. Med. Chem., 44 (11), 4786

Høyem S, Bruheim S, Maelandsmo G, Olberg DE, Brudeli B, Asberg A, Klaveness J, Rongved P (2009)
Didanosine ester prodrugs: synthesis, albumin binding properties and pharmacokinetic studies in rats
Eur J Med Chem, 44 (10), 3874-9
DOI 10.1016/j.ejmech.2009.04.008, PubMed 19433342

Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A (2009)
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease
Clin Infect Dis, 49 (8), 1160-6
DOI 10.1086/605633, PubMed 19751151

Skottheim IB, Stormark K, Christensen H, Jakobsen GS, Hjelmesaeth J, Jenssen T, Reubsaet JL, Sandbu R, Asberg A (2009)
Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients
Clin Pharmacol Ther, 86 (3), 311-8
DOI 10.1038/clpt.2009.82, PubMed 19494810

Publications 2008

Falck P, Asberg A, Byberg KT, Bremer S, Bergan S, Reubsaet JL, Midtvedt K (2008)
Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients
Transplantation, 86 (10), 1379-83
DOI 10.1097/TP.0b013e31818aa4b6, PubMed 19034006

Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JL, Pfeffer P, Hartmann A, Midtvedt K (2008)
Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients
Transplantation, 85 (2), 179-84
DOI 10.1097/TP.0b013e31815feede, PubMed 18212621

Humar A, Asberg A, Kumar D, Hartmann A, Moussa G, Jardine A, Rollag H, Mouas H, Gahlemann CG, Pescovitz MD, VICTOR study group (2008)
An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomes
Am J Transplant, 9 (2), 374-81
DOI 10.1111/j.1600-6143.2008.02501.x, PubMed 19120074

Skottheim IB, Gedde-Dahl A, Hejazifar S, Hoel K, Asberg A (2008)
Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro
Eur J Pharm Sci, 33 (4-5), 317-25
DOI 10.1016/j.ejps.2007.12.009, PubMed 18294823

Publications 2007

Asberg A, Humar A, Rollag H, Jardine AG, Mouas H, Pescovitz MD, Sgarabotto D, Tuncer M, Noronha IL, Hartmann A, VICTOR Study Group (2007)
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients
Am J Transplant, 7 (9), 2106-13
DOI 10.1111/j.1600-6143.2007.01910.x, PubMed 17640310

Falck P, Guldseth H, Asberg A, Midtvedt K, Reubsaet JL (2007)
Determination of ciclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry
J Chromatogr B Analyt Technol Biomed Life Sci, 852 (1-2), 345-52
DOI 10.1016/j.jchromb.2007.01.039, PubMed 17301005

Falck P, Vethe NT, Asberg A, Midtvedt K, Bergan S, Reubsaet JL, Holdaas H (2007)
Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients
Nephrol Dial Transplant, 23 (3), 1048-53
DOI 10.1093/ndt/gfm632, PubMed 17956893

Hjelmesaeth J, Asberg A, Hartmann A, Jenssen T (2007)
The effect of ciclosporin on insulin secretion and resistance - Reply
Nephrol. Dial. Transplant., 22 (11), 3359

Hjelmesaeth J, Hagen LT, Asberg A, Midtvedt K, Størset O, Halvorsen CE, Mørkrid L, Hartmann A, Jenssen T (2007)
The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man
Nephrol Dial Transplant, 22 (6), 1743-9
DOI 10.1093/ndt/gfl820, PubMed 17299003

Hov GG, Sagen E, Bigonah A, Asberg A (2007)
Health-associated reference values for arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) measured with high-performance liquid chromatography
Scand J Clin Lab Invest, 67 (8), 868-76
DOI 10.1080/00365510701429836, PubMed 17852822

Publications 2006

Asberg A, Hansen CN, Reubsaet L (2006)
Determination of ganciclovir in different matrices from solid organ transplanted patients treated with a wide range of concomitant drugs
J Pharm Biomed Anal, 43 (3), 1039-44
DOI 10.1016/j.jpba.2006.08.022, PubMed 17034976

Asberg A, Midtvedt K, Line PD, Narverud J, Holdaas H, Jenssen T, Reisaeter AV, Johnsen LF, Fauchald P, Hartmann A (2006)
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients
Transplantation, 82 (1), 62-8
DOI 10.1097/01.tp.0000225803.04995.2b, PubMed 16861943

Hermann M, Bogsrud MP, Molden E, Asberg A, Mohebi BU, Ose L, Retterstøl K (2006)
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy
Clin Pharmacol Ther, 79 (6), 532-9
DOI 10.1016/j.clpt.2006.02.014, PubMed 16765141

Holdaas H, Hagen E, Asberg A, Lund K, Hartman A, Vaidyanathan S, Prasad P, He YL, Yeh CM, Bigler H, Rouilly M, Denouel J (2006)
Evaluation of the pharmacokinetic interaction between fluvastatin XL and cyclosporine in renal transplant recipients
Int J Clin Pharmacol Ther, 44 (4), 163-71
DOI 10.5414/cpp44163, PubMed 16625985

Voytovich MH, Asberg A, Hjelmesaeth J, Jenssen T, Hartmann A (2006)
Association between insulin resistance and endothelial dysfunction in renal transplant recipients
Clin Transplant, 20 (2), 195-9
DOI 10.1111/j.1399-0012.2005.00465.x, PubMed 16640526

Publications 2005

Borch-Iohnsen B, Asberg A (2005)
Iron status among 3005 women aged 20-55 years in central Norway: The Nord-Trondelag Health Study (the HUNT study) - Response
Scand. J. Clin. Lab. Invest., 65 (7), 627-628

Borch-Iohnsen B, Sandstad B, Asberg A (2005)
Iron status among 3005 women aged 20-55 years in Central Norway: the Nord-Trøndelag Health Study (the HUNT study)
Scand J Clin Lab Invest, 65 (1), 45-54
DOI 10.1080/00365510510013541, PubMed 15859026

Hermann M, Asberg A, Christensen H, Reubsaet JL, Holdaas H, Hartmann A (2005)
Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients
Eur J Clin Pharmacol, 61 (1), 59-62
DOI 10.1007/s00228-004-0874-5, PubMed 15711834

Hjelmesaeth J, Asberg A, Müller F, Hartmann A, Jenssen T (2005)
New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection
Curr Diabetes Rev, 1 (1), 1-10
DOI 10.2174/1573399052952604, PubMed 18220577

Lemahieu WP, Hermann M, Asberg A, Verbeke K, Holdaas H, Vanrenterghem Y, Maes BD (2005)
Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus
Am J Transplant, 5 (9), 2236-43
DOI 10.1111/j.1600-6143.2005.01005.x, PubMed 16095503

Pleym H, Tjomsland O, Asberg A, Lydersen S, Wahba A, Bjella L, Dale O, Stenseth R (2005)
Effects of autotransfusion of mediastinal shed blood on biochemical markers of myocardial damage in coronary surgery
Acta Anaesthesiol Scand, 49 (9), 1248-54
DOI 10.1111/j.1399-6576.2005.00810.x, PubMed 16146460

Voytovich M, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmann A (2005)
Short-term rosiglitazone treatment in renal transplant recipients - Reply
Nephrol. Dial. Transplant., 20 (7), 1512

Publications 2004

Asberg A, Holdaas H (2004)
Fluvastatin and fluvastatin extended release: a clinical and safety profile
Expert Rev Cardiovasc Ther, 2 (5), 641-52
DOI 10.1586/14779072.2.5.641, PubMed 15350166

Bolann BJ, Asberg A (2004)
Analytical quality goals derived from the total deviation from patients' homeostatic set points, with a margin for analytical errors
Scand J Clin Lab Invest, 64 (5), 443-50
DOI 10.1080/00365510410001167, PubMed 15276908

Hermann M, Asberg A, Christensen H, Holdaas H, Hartmann A, Reubsaet JL (2004)
Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients
Clin Pharmacol Ther, 76 (4), 388-91
DOI 10.1016/j.clpt.2004.07.008, PubMed 15470339

Voytovich MH, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmann A (2004)
Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients
Nephrol Dial Transplant, 20 (2), 413-8
DOI 10.1093/ndt/gfh641, PubMed 15615809

Aamodt AH, Borch-Iohnsen B, Hagen K, Stovner LJ, Asberg A, Zwart JA (2004)
Headache prevalence related to haemoglobin and ferritin. The HUNT Study
Cephalalgia, 24 (9), 758-62
DOI 10.1111/j.1468-2982.2004.00756.x, PubMed 15315532

Publications 2003

Asberg A (2003)
Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients
Drugs, 63 (4), 367-78
DOI 10.2165/00003495-200363040-00003, PubMed 12558459

Asberg A, Holdaas H, Jardine AG, Edvardsen C, Hartmann A (2003)
Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation
Clin Transplant, 17 (4), 385-90
DOI 10.1034/j.1399-0012.2003.00063.x, PubMed 12868997

Hagen K, Stovner LJ, Asberg A, Thorstensen K, Bjerve KS, Hveem K (2003)
Headache as a presenting symptom in hereditary - Reply
Ann. Neurol., 53 (1), 145-146

Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Asberg A, Degré M, Fauchald P, Rollag H (2003)
Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study
Nephrol Dial Transplant, 18 (9), 1899-908
DOI 10.1093/ndt/gfg302, PubMed 12937241

Publications 2002

Asberg A, Bjerve KS, Hveem K (2002)
High prevalence of hemochromatosis in Nord-Trondelag - Response
Scand. J. Gastroenterol., 37 (8), 988-989

Asberg A, Hveem K, Krüger O, Bjerve KS (2002)
Persons with screening-detected haemochromatosis: as healthy as the general population?
Scand J Gastroenterol, 37 (6), 719-24
DOI 10.1080/00365520212510, PubMed 12126253

Asberg A, Tretli S, Hveem K, Bjerve KS (2002)
Benefit of population-based screening for phenotypic hemochromatosis in young men
Scand J Gastroenterol, 37 (10), 1212-9
DOI 10.1080/003655202760373443, PubMed 12408528

Christensen H, Asberg A, Holmboe AB, Berg KJ (2002)
Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers
Eur J Clin Pharmacol, 58 (8), 515-20
DOI 10.1007/s00228-002-0516-8, PubMed 12451428

Hermann M, Asberg A, Reubsaet JL, Sather S, Berg KJ, Christensen H (2002)
Intake of grapefruit juice alters the metabolic pattern of cyclosporin A in renal transplant recipients
Int J Clin Pharmacol Ther, 40 (10), 451-6
DOI 10.5414/cpp40451, PubMed 12395977

Lindberg M, Hole A, Johnsen H, Asberg A, Rydning A, Myrvold HE, Bjerve KS (2002)
Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery
Scand J Clin Lab Invest, 62 (3), 189-94
DOI 10.1080/003655102317475443, PubMed 12088337

Molden E, Asberg A, Christensen H (2002)
Desacetyl-diltiazem displays severalfold higher affinity to CYP2D6 compared with CYP3A4
Drug Metab Dispos, 30 (1), 1-3
DOI 10.1124/dmd.30.1.1, PubMed 11744603

Oie E, Yndestad A, Robins SP, Børnerheim R, Asberg A, Attramadal H (2002)
Early intervention with a potent endothelin-A/endothelin-B receptor antagonist aggravates left ventricular remodeling after myocardial infarction in rats
Basic Res Cardiol, 97 (3), 239-47
DOI 10.1007/s003950200017, PubMed 12061394

Publications 2001

Asberg A, Hartmann A, Fjeldså E, Bergan S, Holdaas H (2001)
Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients
Am J Transplant, 1 (4), 382-6
DOI 10.1034/j.1600-6143.2001.10415.x, PubMed 12099384

Asberg A, Hartmann A, Fjeldså E, Holdaas H (2001)
Atorvastatin improves endothelial function in renal-transplant recipients
Nephrol Dial Transplant, 16 (9), 1920-4
DOI 10.1093/ndt/16.9.1920, PubMed 11522880

Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelønning K, Fjøsne U, Halvorsen TB, Smethurst HB, Sagen E, Bjerve KS (2001)
Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons
Scand J Gastroenterol, 36 (10), 1108-15
DOI 10.1080/003655201750422747, PubMed 11589387

Asberg A, Midtvedt K, Vassbotn T, Hartmann A (2001)
Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients
Nephrol Dial Transplant, 16 (7), 1465-70
DOI 10.1093/ndt/16.7.1465, PubMed 11427642

Hole T, Asberg A, Graven T, Lied A, Morstøl TH, Skjaerpe T (2001)
Intra- and interhospital repeatability of radionuclide left ventricular ejection fraction in post-infarction patients
Scand Cardiovasc J, 35 (1), 35-9
DOI 10.1080/140174301750101465, PubMed 11354569

Molden E, Asberg A (2001)
[Metabolic interactions with statins]
Tidsskr Nor Laegeforen, 121 (2), 189-93
PubMed 11475198

Witczak BJ, Asberg A, Hartmann A (2001)
[Acute dialysis-dependent renal failure at the Rikshospital in 1998]
Tidsskr Nor Laegeforen, 121 (10), 1216-9
PubMed 11402747

Publications 2000

Asberg A, Berg KJ, Hartmann A (2000)
Each administration of cyclosporin A enhances skin microvascular reactivity in renal transplant recipients
Microvasc Res, 60 (2), 81-90
DOI 10.1006/mvre.2000.2247, PubMed 10964582

Molden E, Asberg A, Christensen H (2000)
CYP2D6 is involved in O-demethylation of diltiazem. An in vitro study with transfected human liver cells
Eur J Clin Pharmacol, 56 (8), 575-9
DOI 10.1007/s002280000182, PubMed 11151747

Nødtvedt GM, Løvli OC, Asberg A (2000)
[Diagnosis of depleted iron stores--do not use s-iron]
Tidsskr Nor Laegeforen, 120 (14), 1639-41
PubMed 10901073

Thorstensen K, Asberg A, Kvitland M, Svaasand E, Hveem K, Bjerve KS (2000)
Detection of an unusual combination of mutations in the HFE gene for hemochromatosis
Genet Test, 4 (4), 371-6
DOI 10.1089/109065700750065117, PubMed 11216661

Thorstensen K, Kvitland M, Asberg A, Hveem K (2000)
5569G/A polymorphism of the HFE gene: no implications for C282Y genotyping in a hemochromatosis screening study of 65,238 individuals
Genet Test, 4 (2), 147-9
DOI 10.1089/10906570050114858, PubMed 10953954

Publications 1999

Asberg A, Attramadal H, Midtvedt K, Sund S, Hartmann A, Berg KJ (1999)
Gene expression of the renal endothelin system in renal transplant recipients on cyclosporine A based immunosuppression
Transplantation, 67 (7), 1056-60
DOI 10.1097/00007890-199904150-00020, PubMed 10221493

Asberg A, Christensen H, Hartmann A, Carlson E, Molden E, Berg KJ (1999)
Pharmacokinetic interactions between microemulsion formulated cyclosporine A and diltiazem in renal transplant recipients
Eur J Clin Pharmacol, 55 (5), 383-7
DOI 10.1007/s002280050644, PubMed 10456488

Asberg A, Holm T, Vassbotn T, Andreassen AK, Hartmann A (1999)
Nonspecific microvascular vasodilation during iontophoresis is attenuated by application of hyperosmolar saline
Microvasc Res, 58 (1), 41-8
DOI 10.1006/mvre.1999.2153, PubMed 10388602

Christensen H, Carlson E, Asberg A, Schram L, Berg KJ (1999)
A simple and sensitive high-performance liquid chromatography assay of diltiazem and main metabolites in renal transplanted patients
Clin Chim Acta, 283 (1-2), 63-75
DOI 10.1016/s0009-8981(99)00042-x, PubMed 10404732

Hallan S, Asberg A, Indredavik B, Widerøe TE (1999)
A decision analysis of thrombolytic therapy compared with standard therapy in acute ischaemic stroke
J Intern Med, 246 (6), 549-59
DOI 10.1046/j.1365-2796.1999.00535.x, PubMed 10620098

Hallan S, Asberg A, Indredavik B, Widerøe TE (1999)
Quality of life after cerebrovascular stroke: a systematic study of patients' preferences for different functional outcomes
J Intern Med, 246 (3), 309-16
DOI 10.1046/j.1365-2796.1999.00531.x, PubMed 10475999

Åsberg A (1999)
Effects of cyclosporine A on microvascular function and endothelin-1 in renal transplant recipients
University of Oslo, [Oslo], 1 b. (flere pag.)
BIBSYS 990935973, ISBN 82-91094-09-8

Publications 1998

Asberg A, Christensen H, Hartmann A, Berg KJ (1998)
Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1
Clin Transplant, 12 (5), 363-70
PubMed 9787942

Asberg A, Hartmann A, Attramadal H (1998)
Quantification of mRNA levels of endothelin receptor subtypes and preproEndothelin-1 in renal needle biopsies by competitive reverse transcriptase polymerase chain reaction
Scand J Clin Lab Invest, 58 (4), 299-306
DOI 10.1080/00365519850186472, PubMed 9741817

Medbø S, Yu XQ, Asberg A, Saugstad OD (1998)
Pulmonary hemodynamics and plasma endothelin-1 during hypoxemia and reoxygenation with room air or 100% oxygen in a piglet model
Pediatr Res, 44 (6), 843-9
DOI 10.1203/00006450-199812000-00004, PubMed 9853916

Sagedal S, Asberg A, Hartmann A, Bergan S, Berg KJ (1998)
Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients
Clin Transplant, 12 (6), 553-6
PubMed 9850449

Publications 1997

Hallan S, Asberg A (1997)
The accuracy of C-reactive protein in diagnosing acute appendicitis--a meta-analysis
Scand J Clin Lab Invest, 57 (5), 373-80
DOI 10.3109/00365519709084584, PubMed 9279962

Hallan S, Asberg A, Edna TH (1997)
Additional value of biochemical tests in suspected acute appendicitis
Eur J Surg, 163 (7), 533-8
PubMed 9248988

Hallan S, Asberg A, Edna TH (1997)
Estimating the probability of acute appendicitis using clinical criteria of a structured record sheet: the physician against the computer
Eur J Surg, 163 (6), 427-32
PubMed 9231854

Stakkestad JA, Sandberg S, Bjerve KS, Runde I, Asberg A (1997)
Use and usefulness of laboratory handbooks
Scand J Clin Lab Invest, 57 (7), 647-53
DOI 10.3109/00365519709055289, PubMed 9397497

Publications 1995

Hallan S, Lange C, Asberg A (1995)
Abdominal skin temperature in acute appendicitis
Br J Surg, 82 (2), 177
DOI 10.1002/bjs.1800820211, PubMed 7749680

Åsberg A (1995)
Effects of diltiazem in cyclosporine treated renal transplanted patients
A. Åsberg, Oslo, 127 s.
BIBSYS 95201713x

Publications 1994

Asberg A, Midthjell K, Holmen J (1994)
[Utilization of laboratories by primary health care]
Tidsskr Nor Laegeforen, 114 (17), 2035
PubMed 8079342

Asberg A, Midthjell K, Holmen J (1994)
[Variation in the number of clinical chemical analyses requested by primary health care]
Tidsskr Nor Laegeforen, 114 (14), 1617-9
PubMed 8079265

Ravkilde JL, Hørder M, Gerhardt W, Ljungdahl L, Pettersson T, Tryding N, Møller BH, Hamfelt A, Graven T, Asberg A (1994)
[Troponin T in acute myocardial infarction. Diagnosis and prognosis in patients admitted for suspected acute myocardial infarction]
Ugeskr Laeger, 156 (48), 7206-11
PubMed 7817430

Publications 1993

Asberg A (1993)
[Diagnostic tests--use and interpretation]
Tidsskr Nor Laegeforen, 113 (5), 604-8
PubMed 8465320

Ravkilde J, Hørder M, Gerhardt W, Ljungdahl L, Pettersson T, Tryding N, Møller BH, Hamfelt A, Graven T, Asberg A (1993)
Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction
Scand J Clin Lab Invest, 53 (7), 677-85
DOI 10.3109/00365519309092571, PubMed 8272756

Publications 1990

Jensen AE, Reikvam A, Asberg A (1990)
Diagnostic efficiency of lactate dehydrogenase isoenzymes in serum after acute myocardial infarction
Scand J Clin Lab Invest, 50 (3), 285-9
DOI 10.3109/00365519009091580, PubMed 2353157

Jensen AE, Reikvam A, Nordgård S, Pedersen KG, Asberg A (1990)
Diagnostic accuracy of Kodak creatine kinase MB, Stratus creatine kinase MB, and lactate dehydrogenase isoenzyme 1 in serum after acute myocardial infarction
Clin Chem, 36 (10), 1847-8
PubMed 2208667

Publications 1989

Asberg A (1989)
[The hydrogen breath test in the diagnosis of primary lactase deficiency]
Tidsskr Nor Laegeforen, 109 (10), 1097-8
PubMed 2727973

Publications 1987

Asberg A, Haffner F (1987)
Analysis of serum concentration of phenobarbital, phenytoin, carbamazepine and carbamazepine 10,11-epoxide by solvent-recycled liquid chromatography
Scand J Clin Lab Invest, 47 (4), 389-92
PubMed 3602918

Publications 1984

Asberg A, Lehmann EH, Pettersen JE (1984)
Evaluation of dipsticks for the assessment of microhaematuria
Scand J Clin Lab Invest, 44 (5), 377-80
DOI 10.3109/00365518409083824, PubMed 6484479

Publications 1982

Lofterød B, Asberg A, Lossius OP (1982)
[Rectal administration of diazepam in solution in dental treatment of mentally retarded patients]
Tidsskr Nor Laegeforen, 102 (17-18), 978-9
PubMed 7157275

Publications 1973

Lindgren SO, Rinder L, Stålhammar D, Asberg A (1973)
Correlations between brain injuries and mechanical response of the head at impact
Injury, 5 (1), 31-4
DOI 10.1016/s0020-1383(73)80006-3, PubMed 4742523

Publications 1967

Asberg A (1967)
Ultrasonic cinematography of the living heart
Ultrasonics, 5, 113-7
DOI 10.1016/s0041-624x(67)80012-x, PubMed 6039540

Page visits: 364